SCHEMBL25848351

SCHEMBL25848351

C=C(C)C(=O)OCCC(F)(F)C(F)(F)C(F)(F)C(F)(F)CCOc1ccc2cc(-c3ccc(CCCCC)cc3C)c(=O)oc2c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 5/20 0.41
MAOA P21397 2/20 0.41
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
KDM4E B2RXH2 2/20 0.39
HPGD P15428 2/20 0.39
ALDH1A1 P00352 1/20 0.39
GLA P06280 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
PKM P14618 1/20 0.39
MAPK1 P28482 1/20 0.39
ATM Q13315 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
TP53 P04637 1/20 0.39
THRB P10828 1/20 0.38
ACHE P22303 4/20 0.36
BACE1 P56817 3/20 0.36
CA12 O43570 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22625337 0.93 MAOB (0.41) MAOBMAOANPC1RAB9ASMN1; SMN2
SCHEMBL22625183 0.92 MAOB (0.40) MAOBMAOANPC1RAB9ASMN1; SMN2
SCHEMBL25848363 0.92 MAOB (0.40) MAOBMAOANPC1RAB9ASMN1; SMN2
SCHEMBL22625003 0.91 MAOB (0.41) MAOBMAOANPC1RAB9ASMN1; SMN2
SCHEMBL25848306 0.91 MAOB (0.42) MAOBMAOANPC1RAB9ASMN1; SMN2
SCHEMBL22625336 0.91 MAOB (0.39) MAOBMAOANPC1RAB9ASMN1; SMN2
SCHEMBL25848349 0.90 MAOB (0.41) MAOBMAOANPC1RAB9ASMN1; SMN2
SCHEMBL25848332 0.88 MAOB (0.38) MAOBMAOANPC1RAB9ASMN1; SMN2
SCHEMBL25848353 0.87 NPC1 (0.45) MAOBMAOANPC1RAB9ASMN1; SMN2
SCHEMBL21734962 0.85 S1PR1 (0.41) MAOBMAOANPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11702396-B2 Hydrophobic compounds for optically active devices Johnson & Johnson Surgical Vision, Inc. (US) 2023-07-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11702396-B2 Hydrophobic compounds for optically active devices UACA, CRYZ, TRPA1 MAOB 3207/4885MAOA 2922/4885NPC1 1051/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.